The Journal of Clinical Pharmacology

Cover image for The Journal of Clinical Pharmacology

August 2012

Volume 52, Issue 8

Pages 1128–1287

  1. Commentary

    1. Top of page
    2. Commentary
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamic
    6. Special Populations
    7. Drug Interactions
    8. Brief Report
    9. Letter to the Editor
    1. Scientific Considerations for Pharmacoenhancers in Antiretroviral Therapy (pages 1128–1133)

      Vikram Arya, Sarah M. Robertson, Kimberly A. Struble and Jeffrey S. Murray

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011410569

  2. Pharmacokinetics and Pharmacodynamics

    1. Top of page
    2. Commentary
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamic
    6. Special Populations
    7. Drug Interactions
    8. Brief Report
    9. Letter to the Editor
    1. Dosing Celecoxib in Pediatric Patients With Juvenile Rheumatoid Arthritis (pages 1134–1149)

      Sriram Krishnaswami, Matt M. Hutmacher, Jeffery L. Robbins, Akintunde Bello, Christine West and Bradley J. Bloom

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011412184

    2. Mechanistic Modeling of Antigen Sink Effect for Mavrilimumab Following Intravenous Administration in Patients With Rheumatoid Arthritis (pages 1150–1161)

      Bing Wang, Yvonne Y. Lau, Meina Liang, Inna Vainshtein, Mikhail Zusmanovich, Hong Lu, Fabio Magrini, Matthew Sleeman and Lorin Roskos

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011412964

    3. Exposure—Clinical Response Analysis of Paricalcitol in Patients With Chronic Kidney Disease (Stage 5) on Hemodialysis or Peritoneal Dialysis (pages 1162–1173)

      Peter A. Noertersheuser, Rajendra S. Pradhan, Cheri E. Klein, Laura A. Williams, Rameshraja Palaparthy, Tushar S. Garimella, Olaf Lichtenberger and Walid M. Awni

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011412966

  3. Pharmacokinetics

    1. Top of page
    2. Commentary
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamic
    6. Special Populations
    7. Drug Interactions
    8. Brief Report
    9. Letter to the Editor
    1. Population Pharmacokinetics of Pegaptanib in Patients With Neovascular, Age-Related Macular Degeneration (pages 1186–1199)

      Anthony S. Basile, Matt Hutmacher, Dana Nickens, Jace Nielsen, Ken Kowalski, Lloyd Whitfield, Oishi Masayo and Masami Nakane

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011412961

  4. Pharmacodynamic

    1. Top of page
    2. Commentary
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamic
    6. Special Populations
    7. Drug Interactions
    8. Brief Report
    9. Letter to the Editor
    1. Beneficial Effect of Vardenafil on Aortic Stiffness and Wave Reflections (pages 1215–1221)

      Charalambos Vlachopoulos, Dimitrios Terentes-Printzios, Nikolaos Ioakeimidis, Konstantinos Rokkas, Alexios Samentzas, Athanasios Aggelis, Despina Kardara and Christodoulos Stefanadis

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011413586

    2. Characterization of the Human QT Interval: Novel Distribution-Based Assessment of the Repolarization Effects of Moxifloxacin (pages 1222–1239)

      Henry H. Holzgrefe, Georg Ferber, Royce Morrison, Olivier Meyer, Andrea Greiter-Wilke and Thomas Singer

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011409234

  5. Special Populations

    1. Top of page
    2. Commentary
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamic
    6. Special Populations
    7. Drug Interactions
    8. Brief Report
    9. Letter to the Editor
    1. Assessment of the Effects of Renal Impairment on the Pharmacokinetics of the Soluble Guanylate Cyclase Activator Cinaciguat After a Single Intravenous Dose (pages 1240–1247)

      John T. Lettieri, Christian Scheerans, Martin Blunck, Arthur L. Mazzu, Reiner Frey, Wolfgang Mück and Pavur R. Sundaresan

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011410567

  6. Drug Interactions

    1. Top of page
    2. Commentary
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamic
    6. Special Populations
    7. Drug Interactions
    8. Brief Report
    9. Letter to the Editor
    1. Pharmacokinetics and Safety of Coadministered Oseltamivir and Rimantadine in Healthy Volunteers: An Open-Label, Multiple-Dose, Randomized, Crossover Study (pages 1255–1264)

      Georgina Cirrincione-Dall, Barbara J. Brennan, Rosa M. Ballester-Sanchis, Mercidita T. Navarro and Brian E. Davies

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011412960

    2. Omeprazole Impairs the Absorption of Mycophenolate Mofetil But Not of Enteric-Coated Mycophenolate Sodium in Healthy Volunteers (pages 1265–1272)

      M. G. Kees, T. Steinke, S. Moritz, K. Rupprecht, E. M. Paulus, F. Kees, M. Bucher and L. Faerber

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011412968

  7. Brief Report

    1. Top of page
    2. Commentary
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamic
    6. Special Populations
    7. Drug Interactions
    8. Brief Report
    9. Letter to the Editor
    1. Improving the FDA's Advisory Committee Process (pages 1277–1283)

      Eric P. Brass and William R. Hiatt

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270011412962

  8. Letter to the Editor

    1. Top of page
    2. Commentary
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacodynamic
    6. Special Populations
    7. Drug Interactions
    8. Brief Report
    9. Letter to the Editor

SEARCH

SEARCH BY CITATION